Anti-angiogenic drug delivery from hydrophilic resorbable embolization microspheres: an in vitro study with sunitinib and bevacizumab. [electronic resource]
Producer: 20160901Description: 218-27 p. digitalISSN:- 1873-3476
- Angiogenesis Inhibitors -- administration & dosage
- Animals
- Bevacizumab -- administration & dosage
- Cell Line
- Drug Delivery Systems -- methods
- Embolization, Therapeutic -- methods
- Human Umbilical Vein Endothelial Cells -- drug effects
- Humans
- Hydrophobic and Hydrophilic Interactions
- Indoles -- administration & dosage
- Liver Neoplasms -- drug therapy
- Mice
- Microspheres
- Pyrroles -- administration & dosage
- Sunitinib
- Tumor Cells, Cultured
No physical items for this record
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.